XEXP:CA:TSX-iShares Exponential Technologies Index ETF CAD (CAD)

ETF | Others |

Last Closing

CAD 47.74

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

726.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.45 (+1.58%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.31B
PHYS-U:CA Sprott Physical Gold Trust

+0.29 (+1.46%)

CAD 4.76B
XEQT:CA iShares Core Equity Portfolio

+0.39 (+1.22%)

CAD 4.70B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.60 (+1.69%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.59 (+2.50%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.04 (-0.38%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.04 (-0.15%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.53B

ETFs Containing XEXP:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.74% 12% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.74% 11% F 18% F
Trailing 12 Months  
Capital Gain 10.36% 38% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.36% 36% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.08% 79% B- 62% D
Dividend Return 7.08% 79% B- 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.97% 58% F 81% B-
Risk Adjusted Return 101.58% 99% N/A 97% N/A
Market Capitalization 0.01B 25% F 11% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.